LS
Lisata Therapeutics, Inc.
LSTA · NASDAQ
$1.70 -0.58% (-$0.01)
1M +9.68%
Market Cap $15.8M
P/E Ratio -
Div. Yield -
ROE 113.79%
Piotroski F-Score Weak
1/9Valuation
45 /100
Fair P/B 1.92x
P/S 158.45x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 39.35%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 14,621.00%
Op. margin 16,427.00%
FCF margin 12,323.00%
Quality
0 /100
Poor ROE 113.79%
ROA 132.59%
Asset turnover 0.01x
Debt
100 /100
Low Current ratio 3.69x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
61 /100
Moderate EPS volatility 36.23%
Profitable years 0
Beta 0.80x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LSTA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David J. Mazzo
Employees
21
Headquarters
Basking Ridge
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report